(1) Notice about a
patient who has acute rheumatic fever is to be given, as specified in
regulation 8, at the times specified in this regulation.
(2) If a copy of a
medical test is being provided to the Chief Health Officer and —
(a) the
test was carried out to assist in the diagnosis of acute rheumatic fever
during the acute phase — within 14 days after the result of
the test is received by the medical practitioner or nurse practitioner who
requested that the test be carried out; or
(b)
otherwise — within 30 days after the result of the test is
received by the medical practitioner or nurse practitioner who requested that
the test be carried out.
(3) If a copy of a
medical specialist’s report is being provided to the Chief Health
Officer and —
(a) the
report is based on a consultation with the patient during the acute
phase — within 14 days after the medical specialist finalises
the report; or
(b) the
report is based on a consultation with the patient that was not during the
acute phase — within 30 days after the medical specialist
finalises the report.
(4) If the person
diagnosing or treating the patient is an obstetrician and the information
being provided to the Chief Health Officer does not include a copy of a
medical test or a specialist medical report — within 14 days
of the obstetrician becoming aware that the patient has acute rheumatic fever.
(5) If the information
described in regulation 8(b) is being provided to the Chief Health
Officer — within 14 days after the patient is diagnosed with,
or treated for, acute rheumatic fever.
[Regulation 9 amended: Gazette 10 Jan 2017
p. 278.]